Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
2011 · Annals of General Psychiatry · 46 citations
https://doi.org/10.1186/1744-859x-10-1
W
Weining Robieson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
2.5K
Citations
26
h-index
35
i10-index
Weining Robieson is an academic researcher from AbbVie (United States). The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Neurological disorders and treatments & Restless Legs Syndrome Research. The author has an h-index of 26, co-authored 90 publications.
ORCID: 0000-0003-0557-1075Papers by this author
worksABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension
2016 · Alzheimer s Research & Therapy · 38 citations
https://doi.org/10.1186/s13195-016-0210-1
Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response
2013 · Translational Psychiatry · 25 citations
https://doi.org/10.1038/tp.2013.22
Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients
2016 · npj Parkinson s Disease · 15 citations
https://doi.org/10.1038/npjparkd.2016.20
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
2018 · npj Parkinson s Disease · 9 citations
https://doi.org/10.1038/s41531-017-0040-2
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies
2024 · Journal of Child and Adolescent Psychopharmacology · 5 citations
https://doi.org/10.1089/cap.2023.0080
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat